
---
nice.evidencecategory: 
---

### Evidence Statement CG66ES122
A post hoc analysis of the RENAAL study253 found no significant differences between patients
treated with losartan or placebo in terms of glycaemic levels, lipid profile or serum uric acid
after 3.4 years of follow-up. Level 1+

[@2005]

